Is COMPASS Pathways plc (CMPS) Stock a Psychedelic Medicine Opportunity After Positive COMP360 Data?

TheFly reported connected July 7 that Oppenheimer reaffirmed its Outperform standing and $20 terms people connected CMPS shares pursuing caller Phase 3 COMP006 26-week results. The steadfast stated that the information further enactment the sustained effectiveness of COMP360 successful patients with treatment-resistant depression. Oppenheimer believes the latest findings fortify the company's regulatory outlook, including a planned NDA submission successful the 4th quarter, portion reinforcing the imaginable for the archetypal FDA support of a classical psychedelic therapy. The steadfast besides views the stock's commercialized accidental arsenic not afloat reflected successful its existent valuation up of a imaginable first-half 2027 launch.

On the aforesaid day, COMPASS Pathways plc (NASDAQ:CMPS) reported 26-week results from Part B of its ongoing Phase 3 COMP006 survey evaluating COMP360 for treatment-resistant depression. The findings showed sustained objective benefits and confirmed the therapy's accelerated onset of enactment successful a colonisation with long-standing, difficult-to-treat depression. The institution said 39% of patients receiving the 25 mg dose achieved a clinically meaningful betterment by Week 6, with benefits mostly maintained done Week 26. COMP360 besides continued to show a favorable information profile.

COMPASS Pathways plc (NASDAQ:CMPS) is simply a UK-based biotechnology institution processing psychedelic-based therapies for intelligence wellness disorders. Its pb candidate, COMP360, is simply a synthetic psilocybin attraction combined with intelligence enactment for treatment-resistant depression.

While we admit the imaginable of CMPS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.